Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563,000
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
87,458
-
Shares change
-
-16,853
-
Total reported value, excl. options
-
$98,000
-
Value change
-
-$87,297
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.12
Significant Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q1 2022
9 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock as of Q1 2022.
Bluejay Diagnostics, Inc. - Common Stock (BJDX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,458 shares
of 563,000 outstanding shares and own 16% of the company stock.
Largest 9 shareholders include PERKINS CAPITAL MANAGEMENT INC (22,500 shares), BlackRock Inc. (20,835 shares), JANE STREET GROUP, LLC (15,913 shares), Verition Fund Management LLC (15,000 shares), Tower Research Capital LLC (TRC) (7,119 shares), UBS Group AG (5,591 shares), ADVISOR GROUP HOLDINGS, INC. (500 shares), VANGUARD GROUP INC (0 shares), and TWO SIGMA SECURITIES, LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.